CA46

Cat.No.: CSC-C9093W

Species: Human

Source: B lymphocyte

Morphology: single cells in suspension

Inquire for Price

Specification
Q & A
Customer Review

Cat.No.

CSC-C9093W

Description

established from the ascites fluid of a patient with American-type Burkitt lymphoma; cells were described to be EBNA-negative, to carry the t(8;14) and to express BCL2 and MYC mRNA

Species

Human

Source

B lymphocyte

Recommended Medium

90% RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3 + 10% h.i. FBS

Morphology

single cells in suspension

Storage and Shipping

frozen with 70% medium, 20% FBS, 10% DMSO

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

What are the ethical considerations in acquiring tumor samples for cell line establishment?

Ethical considerations include obtaining informed consent, ensuring patient confidentiality, and adhering to ethical guidelines and regulations governing human sample procurement.

Ask a Question

Average Rating: 5.0 | 1 Scientist has reviewed this product

A valuable tool

The cells accelerated my research progress, and I was able to generate meaningful data quickly. A valuable tool for time-conscious researchers.

05 Nov 2023

Ease of use
After sales services
Value for money

Write your own review

You May Also Need

CM-1002X

SuperCult® RPMI-1640 with L-glutamine & HEPES

INQUIRY

CS-001Y

PremSera® FBS

INQUIRY

CAL-39

Description: Established from the primary lesion resected from a 76-year-old woman with bulky, moderately differentiated squamous cell carcinoma of the vulva in 1984; cells were reported to express an elevated number of high affinity EGF receptors, to carry gene amplification at 11q13 and to be tumorigenic in nude mice

Cat#: CSC-C0316 INQUIRY

View Product

EGI-1

Description: Established from the solid tumor of a 52-year-old Caucasian man with advanced stage malignant bile duct carcinoma (patient had not received any chemotherapy prior to cell explantation) in 1984 and three consecutive passages in female nu/nu mice (NMRI); primary tumor histology: large cell adenocarcinoma of low differentiation, metastasizing (ascites in patient); human character of cell line confirmed by karyotype in passage #34 of in vitro culture (1986)

Cat#: CSC-C0433 INQUIRY

View Product

AC-1M81

Description: Subclone of ACH1P which was established by fusion of the JEG-3-derived HGPRT-defective mutant cell line AC1-1 with primary male trophoblast cells isolated from term human chorion laeve; described as possessing both, a distinct karyotype and a distinct expression pattern of tumor-related genes

Cat#: CSC-C0485 INQUIRY

View Product

AC-1M88

Description: One of five phenotypically and cytogenetically distinct subclones of a hybrid (ACH1P) formed by fusing an HGPRT-defective mutant (AC1-1) of JEG-3 human choriocarcinoma with primary human trophoblast (chorion laeve) cells

Cat#: CSC-C0486 INQUIRY

View Product

ACH1P

Description: Established by somatic hybridization of primary male trophoblast cells and the HGPRT-defective choriocarcinoma cell line AC1-1 which was originally derived from cell line JEG-3

Cat#: CSC-C0496 INQUIRY

View Product

NTERA-2

Description: NTERA-2 was cloned from cell line TERA-2 which was derived from a metastatic teratocarcinoma of a 22-year-old Caucasian male; cell line also known as NT-2

Cat#: CSC-C0535 INQUIRY

View Product

For research use only. Not for any other purpose.